期刊文献+

急性白血病患者骨髓MK和VEGF基因表达及临床意义的探讨 被引量:1

Expressions and significance of MK and VEGF in acute leukemia bone marrow
原文传递
导出
摘要 目的:研究急性白血病(AL)患者MK和VEGF基因的表达水平及其与血管新生、临床预后的关系。方法:应用实时荧光定量PCR检测95例不同病程的AL患者骨髓单个核细胞MK和VEGF mRNA的表达。结果:急性非淋巴细胞白血病(AML)和急性淋巴细胞白血病(ALL)患者MK和VEGF表达量均明显高于对照组,P=0.000 0。初治/复发组AL患者MK、VEGF基因表达水平较对照组及完全缓解组升高,完全缓解组MK和VEGF表达水平仍较对照组高,P均<0.01。缓解组MK表达水平与VEGF和骨髓原幼细胞数存在显著相关性,r=0.673,P<0.01;r=0.468,P<0.01。复发组MK和VEGF之间也存在相关性,r=0.526,P<0.05。初治组和对照组MK、VEGF、骨髓原幼细胞数之间无明显相关性。结论:MK、VEGF高表达可能与AL血管新生、病情进展有关,且两者存在一定的协同作用,共同监测可能对研究急性白血病的发病及指导治疗和估计预后有一定意义。 OBJECTIVE.. To explore the expression and correlation of MK and VEGF gene in acute leukemia (AL), and evaluate their relationship with angiogenesis and prognosis. METHODS.. The expression level of MK and VEGF in 95 AL patients in different phase were detected by Taqman real-time fluorescent quantitative RT PCR. RESULTS: The expressions level of MK and VEGF in acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL) were significantly higher than those in control group (P=0. 000 0) ; The expression level of MK and VEGF in untreated/ relapsed groups was significantly higher than that in control/remission groups (P〈0.01); The expression level of MK and VEGF in remission group was also significantly higher than that in control group(P〈0.01). Linear correlation was observed between the level of MK and VEGF in relapsed group(r=0. 526,P〈0.05). In remission group, MK had linear relationship with VEGF and the ratio of the blast cell in bone marrow(r= 0. 673,P〈0.01; r= 0. 468,P〈 0.01 ), but in untreated/control groups, there was no linear relationship among MK, VEGF level and the ratio of the blast cell in bone marrow. CONCLUSIONS.. The high expressions of MK and VEGF are correlated with angiogenesis and prognosis in AL, and there is synergistic effect between MK and VEGF. Monitoring MK and VEGF can be used to guide the treatment and to estimate prognosis.
出处 《中华肿瘤防治杂志》 CAS 2009年第9期690-693,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 白血病 血管内皮生长因子类 中期因子 leukemia vescular endothelial growth factors midkine
  • 相关文献

参考文献11

  • 1Ikematsu S, Yano A, Aridome K, et al. Serum midkine levels are increased in patients with various types of carcinomas[J]. Br J Cancer,2000, 83(6) : 701-706.
  • 2Kato M, Shinozawa T, Kato S,et al. Increased midkine expression in intrahepatie cholangiocarcinoma: immunohistochemical and in situ hybridization analyses[J]. Liver, 2000, 20(3): 216- 221.
  • 3Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor[J]. Endocr Rev, 1997,18(1) :4-25.
  • 4Qi M, Ikematsu S, Ichihara Tanaka K, et al. Midkine rescues Wilms' tumor cells from cisplatin induced apoptosis: regulation of Bcl 2 expression by Midkine[J]. J Biochem (Tokyo), 2000, 127(2):269-277.
  • 5Adachi Y, Matsubara S, Muramatsu T,et al. Midkine promot er-based adenoviral suicide gene therapy to midkine-positive pediatrictumor[J]. J Pediatr Surg, 2002, 37(4):588-592.
  • 6杨琳,董作仁,潘崚,罗建民,徐世荣.中期因子在急性髓系白血病患者的表达及临床意义[J].中国实验血液学杂志,2006,14(3):442-445. 被引量:8
  • 7王谊,侯梅,张智慧.VEGF在恶性淋巴瘤患者血清与骨髓中的表达及其临床意义的研究[J].中华肿瘤防治杂志,2007,14(6):433-435. 被引量:3
  • 8Westphal J R, Van't Hullenaar R, Peek R, et al. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts invivo[J]. Int J Cancer, 2000, 86(6) :768-776.
  • 9石秀换,李云霞.非小细胞肺癌组织中期因子蛋白表达及其临床意义的研究[J].中华肿瘤防治杂志,2008,15(12):913-916. 被引量:6
  • 10Muramaki M, Miyake H, Hara I, et al. Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy[J]. Clin Cancer Res, 2003, 9(14) :5152-5160.

二级参考文献34

  • 1[1]Folkman J.What is the evidence that tumors are angiogenesis is dependent[J].J Natl Cancer Inst,1990,82 (1):4-6.
  • 2[2]Weidner N,Semple J P,Welch W R,et al.Tumour angiogenesis and metastasis correlation in invasive breast carcinoma.[J].N Engl J Med,1991,324 (1):1-8.
  • 3[3]Tomomur M,Muramatasu T.cDNA cloning and sequencing of anew gene intensely expressed in carly differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis[J].Biochem Biophys Res Commun,1998,151 (3):1312-1318.
  • 4[4]Ohama H,Malsubara S,Guenet J,et al.The midkine family of growth/differentiantion factors; structure of a Midkine-relation-ship among member of the midkine family[J].Jbiochem,1994,115 (3):516-522.
  • 5[5]Satyamoorthy K,Oka M,Herlyn M.An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin[J].Pigment Cell Res,2000,13 (Supple 8):87-93.
  • 6[6]Qi M,Ikematsu S,Ichihara-Tanaka K,et al.Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis:regulation of Bcl-2 expression by midkine[J].J Biochem,2000,127 (2):269-277.
  • 7[7]Waichi S,Kenji K,Yukio Y,et al.Midkine is involved in netrophil infiltration into the tubulointerstitium in ischemic renal injury[J].J Immu,2001,167 (6):3463-3469.
  • 8[9]Shibata Y,Muramatsu T,Hirai M,et al.Nucle targeting by the groth factor midkine[J].Molecular and Cellular Biology,2002,22 (19):6788-6796.
  • 9[10]Mashour G A,Ratner N,Khan G A,et al.The angiogenic factor midkine is aberrantly expressed in NF1 deficient Schwann cells and is a mitogen for neurofibroma derived Sdhwann cells and is a mitogen for neurofibroma derived cells[J].Oncogene,2001,20 (1):97-105.
  • 10杨天楹.急性非淋巴细胞白血病的形态学分型见:张之南,沈悌主编血液病诊断及疗效标准.第二版.北京:科学出版社,1999:171-173

共引文献19

同被引文献14

  • 1Kadomatsu K, Tomomura M, Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentia- tion stages of embryonal carcinoma cells and in mid-gestation pe- riod of mouse embryogenesis[J]. Biochem Biophys Res Corn-mun, 1988,151(3) : 1312-1318.
  • 2Kadomatsu K, Kishida S,Tsubota S. The heparin-binding growth factor midkine: the biological activities and candidate receptors [J]. J Biochem,2013,153(6) :511-521.
  • 3Muramatsu T. Midkine,a heparin-binding cytokine with multiple roles in development, repair and diseases[J]. Proc Jpn Acad Set B Phys Biol Sci,2010,86(4) :410-425.
  • 4Sakamoto K,Kadomatsu K. Midkine in the pathology of cancer, neural disease, and inflammation [J]. Pathol Int, 2012, 62 (7) : 445-455.
  • 5Scheper MA,Duarte EC,Intapa C,et al. Expression of midkine in ameloblastomas and its correlation with clinicopathologic param- eters[J]. Oral Surg Oral Med Oral Pathol Oral Radiol,2012,114 (4) :497-502.
  • 6Chiu TJ, Chen YJ, Rau KM, et al. Midkine neurite growth-pro- moting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma[J]. Biomarkers,2013,18(8) : 687-698.
  • 7Kadomatsu K, H agihara M, Akhter S, et al. Midkine induces the transformation of NIH3T3 cells[J]. Br J Cancer, 1997,75 (3) : 354-359.
  • 8Stoica GE, Kuo A, Powers C, et al. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for differ- ent cell types[J]. J Biol Chem,2002,277(39) :35990-35998.
  • 9Wang Q, Huang Y, Ni Y, et al. siRNA targeting midkine inhibits gastric cancer ceils growth and induces apoptosis involved caspase-3,8,9 activation and mitochondrial depolarization [J]. J Biomed Sci,2007,14(6) :783-795.
  • 10Yu L,Fan Y, Chen B, et al. Suppression of metastasis of human pancreatic cancer cells to the liver by small interfering RNA-me- diated targeting of the midkine gene[J]. Oncol Lett, 2013,6 (5) : 1338-1342.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部